MEETING BVK/SBP ‐ PROGRAM BSPHO ‐ BPCRN Thursday, March 12th 2015 –Palais des Congrès, Esplanade de l’Europe 2/A, Liège MORNING PROGRAM Chair: Marie‐Françoise Dresse, Jutte van der Werff ten Bosch, 11h – 11h15: Introduction 11h15 – 12h00: Evelyne Jacqz Aigrain, CHR Citadelle, Liège Brussels University Hospital Pediatric Pharmacology and Pharmacogenetics – Hôpital Robert Debré ‐ Paris Pharmacogenetics and drug effects in children with ALL 12h00 – 12h30: Veerle Labarque Leuven University Hospital ITP: Idiopathic Thrombocytopenic Purpura in Children: state of the art and expectations for the near future AFTERNOON PROGRAM Chair: 14h30 – 14h50 : Marie‐Françoise Dresse, CHR Citadelle, Liège Jutte van der Werff ten Bosch, Brussels University Hospital Jutte van der Werff ten Bosch, Brussels University Hospital Presentation of the BPCRN 14h50 – 15h10: An Van Damme, UC Louvain, Research Department Presentation of the BSPHO 15h10 – 15h30: Koen Norga, Antwerp University Hospital, Paediatric Haematology / Oncology Vice‐Chair Paediatric Committee (PDCO), European Medicines Agency (EMA) The role of academia in commercial drug development for children with Cancer under the EU Paediatric Regulation